-+ 0.00%
-+ 0.00%
-+ 0.00%

ERS 2026 | MABWELL MEMBENTANGKAN HASIL KLINIKAL FASA IB/IIA ANTIBODI MONOKLONAL ANTI-ST2 9MW1911 PADA PESAKIT COPD

Reuters·09/04/2026 13:02:10